A Phase IIb Randomized Controlled Trial of the TLPLDC Vaccine as Adjuvant Therapy After Surgical Resection of Stage III/IV Melanoma: A Primary Analysis

Timothy J. Vreeland, Guy T. Clifton, Diane F. Hale, Robert C. Chick, Annelies T. Hickerson, Jessica L. Cindass, Alexandra M. Adams, Phillip M. Kemp Bohan, Robert H.I. Andtbacka, Adam C. Berger, James W. Jakub, Jonathan Sussman, Alicia M. Terando, Thomas E. Wagner, George E. Peoples, Mark B. Faries